BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, vol.1861, no.2, pp.49-57, 2017 (SCI-Expanded)
Background: The outcome of triple negative breast cancer is still poor and requires improvement with better therapy options. Autophagy has recently been shown to play a role in anticancer drug resistance. Therefore, we investigated if the effectiveness of doxorubicin was augmented by the inhibition of autophagy.